ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04795141 |
|
Recruitment Status :
Terminated
(The sponsor's development strategy is adjusted.)
First Posted : March 12, 2021
Last Update Posted : September 22, 2022
|
Sponsor:
Inmagene Biopharmaceuticals
Collaborator:
Affibody
Information provided by (Responsible Party):
Inmagene Biopharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | July 11, 2022 |
| Actual Study Completion Date : | August 30, 2022 |